Clinical Trial Update: Serotonin 1A Agonists and Cognition in Schizophrenia [Phase 3]

View source ↗

Summary

The document reports the completion of a Phase 3 trial evaluating a serotonin 1A agonist's effect on cognition in people with schizophrenia and schizoaffective …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Snippet

Sponsor: Northwestern University | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 3 | Status: COMPLETED